Soriatane
designed to support skin health by mitigating symptoms of severe psoriasis.
Strengths: 10mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Neotigason
- Therapeutic class
Retinoid
- Pharmacological class
Vitamin A Derivative
- Known off-label uses
ichthyosis
- Minor side effects
dry lips; xerosis; epistaxis; alopecia
- Moderate side effects
hypertriglyceridaemia; dry eyes
- Dosage forms
Capsule, hard
- Administration route
Oral use
- Patient summary
designed to support skin health by mitigating symptoms of severe psoriasis.
- Prescription status
POM
- Manufacturer
Actavis
- Onset Time
2–4 weeks
- Duration
variable
- Storage instructions
Protect from light and store in a cool place.
- Drug interactions
alcohol; vitamin a; methotrexate
- Age restrictions
Not typically indicated for use in children.
- Pregnancy and breastfeeding
Pregnancy: Absolute contraindication. Breastfeeding: Not permitted.
Contraindications
pregnancy; breastfeeding; severe hepatic impairment; severe renal impairment; hyperlipidaemia
Precautions and warnings
strict pregnancy prevention required; avoid blood donation during and for a period after treatment; monitor liver function test results
Serious side effects
teratogenicity — requires immediate medical attention; pancreatitis — requires immediate medical attention
Mechanism of action
As a systemic aromatic retinoid, it acts by regulating cell proliferation and differentiation in the skin. It normalizes hyperkeratinization and suppresses the inflammatory process characteristic of dermatological disorders.
Soriatane
designed to support skin health by mitigating symptoms of severe psoriasis.
Editorial Notes
- Active ingredient(s): Acitretin
- Listed indication(s): Psoriasis
Available option
- 30 tablets - 10 mg1463-10-mg-17665